InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+15.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Stanker James H. Officer active across 1 company, notably Processa Pharmaceuticals, Inc.. Cumulatively, 8 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €6k. History available since 21 June 2021. The latest transaction was filed on 12 October 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Stanker James H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
1,675 sharesCommon StockSEC:0000897069-24-001613:0
1,675 sharesCommon StockSEC:0000897069-24-000923:0
15,000 shares@ US$0.3315.4% of flowCommon StockSEC:0000897069-23-001464:0
22,500 shares@ US$0.2416.7% of flowCommon StockSEC:0000897069-23-001436:0
12,500 shares@ US$0.8030.5% of flowCommon StockSEC:0001567619-23-002403:0
7,601 sharesCommon StockSEC:0001567619-22-015307:0
7,601 sharesCommon StockSEC:0001567619-21-014749:0
1,000 shares@ US$6.8123.0% of flowCommon StockSEC:0001567619-21-012484:0
Canonical exit: 19 Sept 2021 (T+90)
8 of 8 declarations
About Stanker James H
Stanker James H is a declarant and has 10 filings in total. In the 10 most recent filings we hold, relating to Processa Pharmaceuticals, Inc., the transactions run from 2021-06-22 to 2024-08-02, with EUR 11,433 of buys and EUR 0 of sells, and the most frequent transaction nature is Attribution.
